ArticleBioengineering & translational medicine2024

Engineering a "muco-trapping" ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19.

Karthik Tiruthani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.